BDBM620884 (3S,4S) or (3R,4R) 4-(4-{6- chloro-2-[(1-cyclopropyl-5- methyl-1H-pyrazol-4- yl)amino]quinazolin-7- yl}piperazin-1-yl)-4- methyloxolan-3-ol::US20230303540, Example Ex-6.18::US20230303540, Example Ex-6.22

SMILES Cc1c(Nc2ncc3cc(Cl)c(cc3n2)N2CCN(CC2)C2(C)COCC2O)cnn1C1CC1

InChI Key InChIKey=KMTNFFHTFSZLMV-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 620884   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM620884((3S,4S) or (3R,4R) 4-(4-{6- chloro-2-[(1-cycloprop...)
Affinity DataIC50:  33.5nMAssay Description:The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM620884((3S,4S) or (3R,4R) 4-(4-{6- chloro-2-[(1-cycloprop...)
Affinity DataIC50:  0.322nMAssay Description:The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent